Compare Abbott Laboratories (ABT) vs Core Scientific Inc (CORZ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Core Scientific Inc — how do they compare? Abbott Laboratories trades at $95.4 (market cap $166.94B), while Core Scientific Inc trades at $22.37 (market cap $6.85B). The key difference: Abbott Laboratories is far larger — about 24.4× Core Scientific Inc's market cap, and Abbott Laboratories pays a 2.63% dividend while Core Scientific Inc pays none. Which is the better fit depends on your goals.
| ABT | CORZ | |
|---|---|---|
Market Cap | $166.94B | $6.85B |
Sector | Health | Technology |
52-Week High | $136.62 | $29.16 |
52-Week Low | $82.57 | $12.51 |
Enterprise Value | $193.69B | $7.90B |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
CORZ trades at $22.80, up 6.39% today, while showing bearish technical signals with a net cash outflow of $525.6M in 2025. The company is pivoting from Bitcoin mining to AI colocation, with Q1 2026 colocation revenue surging to $77.5M and gross margins of 57%. Despite missing earnings estimates for three consecutive quarters, analyst consensus remains strongly bullish with 86% buy ratings and a $33.43 price target.
The stock presents a high-risk, high-reward opportunity as the AI infrastructure transition accelerates. Near-term execution risks and negative profitability metrics contrast with substantial growth potential in the AI data center market. Wall Street optimism appears to outweigh current financial challenges, but investors should monitor cash flow improvements and contract execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Core Scientific Inc
Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →
